CA2960655C - Peptide microarrays and novel biomarkers for celiac disease - Google Patents
Peptide microarrays and novel biomarkers for celiac disease Download PDFInfo
- Publication number
- CA2960655C CA2960655C CA2960655A CA2960655A CA2960655C CA 2960655 C CA2960655 C CA 2960655C CA 2960655 A CA2960655 A CA 2960655A CA 2960655 A CA2960655 A CA 2960655A CA 2960655 C CA2960655 C CA 2960655C
- Authority
- CA
- Canada
- Prior art keywords
- array
- polypeptide
- peptide
- seq
- features
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/10—Libraries containing peptides or polypeptides, or derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/02—Nutritional disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048537P | 2014-09-10 | 2014-09-10 | |
| US62/048,537 | 2014-09-10 | ||
| PCT/US2015/049528 WO2016040703A1 (en) | 2014-09-10 | 2015-09-10 | Peptide microarrays and novel biomarkers for celiac disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2960655A1 CA2960655A1 (en) | 2016-03-17 |
| CA2960655C true CA2960655C (en) | 2024-03-19 |
Family
ID=55459587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2960655A Active CA2960655C (en) | 2014-09-10 | 2015-09-10 | Peptide microarrays and novel biomarkers for celiac disease |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10900964B2 (OSRAM) |
| EP (1) | EP3191629A4 (OSRAM) |
| JP (3) | JP6887945B2 (OSRAM) |
| AU (3) | AU2015314934A1 (OSRAM) |
| CA (1) | CA2960655C (OSRAM) |
| NZ (1) | NZ730519A (OSRAM) |
| WO (1) | WO2016040703A1 (OSRAM) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6887945B2 (ja) | 2014-09-10 | 2021-06-16 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
| NZ742318A (en) | 2015-10-29 | 2019-10-25 | Vibrant Holdings Llc | Methods, tools, and tool assemblies for biomolecular analysis using microarrays |
| CN109790203A (zh) * | 2016-06-20 | 2019-05-21 | 健康之语公司 | 自身免疫疾病的诊断和治疗方法 |
| WO2017223116A2 (en) | 2016-06-20 | 2017-12-28 | Healthtell Inc. | Methods for differential diagnosis of autoimmune diseases |
| CN110073217A (zh) | 2016-10-04 | 2019-07-30 | 豪夫迈·罗氏有限公司 | 用于鉴定合成分类器的系统和方法 |
| US11371990B2 (en) | 2016-11-11 | 2022-06-28 | Cowper Sciences Inc. | Methods for identifying candidate biomarkers |
| CN107176974B (zh) * | 2017-06-06 | 2021-04-13 | 中国医学科学院北京协和医院 | ω-5-醇溶蛋白特异的CD4+T细胞表位及其应用 |
| WO2019136322A1 (en) * | 2018-01-05 | 2019-07-11 | Centrillion Technologies, Inc. | Methods for fabricating high resolution dna array and its application in sequencing |
| JP7664838B2 (ja) * | 2018-10-08 | 2025-04-18 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | セリアック病をモニタリングするためのｔＴＧ－ＤＧＰバイオマーカー |
| CN111926051A (zh) * | 2020-07-10 | 2020-11-13 | 内蒙古燕谷坊全谷物产业发展有限责任公司 | 一种燕麦肽粉及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19630557C2 (de) | 1996-07-18 | 1998-07-02 | Schuppan Detlef Priv Doz Dr Dr | Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie |
| EP1197755A1 (en) | 2000-10-11 | 2002-04-17 | Pepscan Systems B.V. | Identification of protein binding sites |
| AU2002241504A1 (en) | 2000-11-13 | 2002-06-18 | Picoliter Inc. | Integrated device with surface-attached molecular moieties and related machine-readable information |
| JP2002320341A (ja) | 2001-02-14 | 2002-10-31 | Sony Corp | 充放電装置および方法、電力供給装置および方法、電力供給システムおよび方法、プログラム格納媒体、並びにプログラム |
| WO2003046508A2 (en) | 2001-11-09 | 2003-06-05 | Biomicroarrays, Inc. | High surface area substrates for microarrays and methods to make same |
| GB0212885D0 (en) * | 2002-06-05 | 2002-07-17 | Isis Innovation | Therapeutic epitopes and uses thereof |
| US7290169B2 (en) | 2004-04-06 | 2007-10-30 | Hewlett-Packard Development Company, L.P. | Core-level processor lockstepping |
| CA2732108A1 (en) | 2008-07-28 | 2010-02-04 | Children's Medical Center Corporation | Prominin-1 peptide fragments and uses thereof |
| MX346450B (es) * | 2008-11-30 | 2017-03-17 | Immusant Inc * | Composiciones y métodos para el tratamiento de la enfermedad celíaca. |
| FR2949782B1 (fr) * | 2009-09-04 | 2015-10-16 | Isp Investments Inc | Peptide activateur de la transglutaminase et composition cosmetique ou pharmaceutique le contenant. |
| CA3191015A1 (en) * | 2012-02-07 | 2013-08-15 | Vibrant Holdings, Llc | Substrates, peptide arrays, and methods |
| DE102013214247A1 (de) | 2013-07-22 | 2015-01-22 | Bayerische Motoren Werke Aktiengesellschaft | Blindnietmutter für die Verbindung zweier Bauteile |
| CN103675291A (zh) * | 2013-11-25 | 2014-03-26 | 南昌大学 | 一种基于t细胞表位筛查低乳糜泻毒性小麦品种的方法 |
| JP6887945B2 (ja) | 2014-09-10 | 2021-06-16 | ヴィブラント ホールディングス リミテッド ライアビリティ カンパニー | セリアック病に関するペプチドマイクロアレイおよび新規バイオマーカー |
-
2015
- 2015-09-10 JP JP2017513482A patent/JP6887945B2/ja active Active
- 2015-09-10 AU AU2015314934A patent/AU2015314934A1/en not_active Abandoned
- 2015-09-10 EP EP15839169.8A patent/EP3191629A4/en active Pending
- 2015-09-10 NZ NZ730519A patent/NZ730519A/en unknown
- 2015-09-10 WO PCT/US2015/049528 patent/WO2016040703A1/en not_active Ceased
- 2015-09-10 US US15/510,223 patent/US10900964B2/en active Active
- 2015-09-10 CA CA2960655A patent/CA2960655C/en active Active
-
2019
- 2019-02-08 AU AU2019200921A patent/AU2019200921B2/en active Active
-
2020
- 2020-12-21 US US17/129,091 patent/US20210285948A1/en active Pending
-
2021
- 2021-05-19 JP JP2021084301A patent/JP7256229B2/ja active Active
- 2021-06-16 AU AU2021203987A patent/AU2021203987A1/en not_active Abandoned
-
2023
- 2023-03-30 JP JP2023054447A patent/JP7781813B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20210285948A1 (en) | 2021-09-16 |
| AU2015314934A1 (en) | 2017-04-20 |
| WO2016040703A1 (en) | 2016-03-17 |
| JP7256229B2 (ja) | 2023-04-11 |
| JP6887945B2 (ja) | 2021-06-16 |
| JP2017532544A (ja) | 2017-11-02 |
| JP7781813B2 (ja) | 2025-12-08 |
| US20170269077A1 (en) | 2017-09-21 |
| NZ742911A (en) | 2024-02-23 |
| NZ730519A (en) | 2018-10-26 |
| EP3191629A4 (en) | 2018-07-11 |
| JP2021144040A (ja) | 2021-09-24 |
| AU2019200921B2 (en) | 2021-07-01 |
| AU2021203987A1 (en) | 2021-07-08 |
| US10900964B2 (en) | 2021-01-26 |
| EP3191629A1 (en) | 2017-07-19 |
| CA2960655A1 (en) | 2016-03-17 |
| JP2023093494A (ja) | 2023-07-04 |
| AU2019200921A1 (en) | 2019-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019200921B2 (en) | Peptide microarrays and novel biomarkers for celiac disease | |
| JP6027215B2 (ja) | セリアック病の処置のための組成物および方法 | |
| PT2083856E (pt) | Péptidos para a dessensibilização contra alergénios | |
| BR122013006960A2 (pt) | Peptídeo sintético que é imunologicamente reativo com um anticorpo de proteína anti-citrulinado, seu uso e seu método de identificação, bem como kit compreendendo o referido peptídeo | |
| CN103502515B (zh) | 自身免疫疾病的抗原替代物 | |
| CN101282989A (zh) | 用于诊断风湿性疾病的方法 | |
| AU2003275941A1 (en) | Recombinant protein variants | |
| CA2925000A1 (en) | Compositions and methods related to oat sensitivity | |
| JP7664838B2 (ja) | セリアック病をモニタリングするためのｔＴＧ－ＤＧＰバイオマーカー | |
| LAHDEAHO et al. | Activation of Celiac Disease Immune System by Specific ax-Gliadin Peptides | |
| AU2012205288B2 (en) | DNA-sequence and recombinant production of group 4 major allergens from cereals | |
| US20170296652A1 (en) | Methods and compositions involving recombinant hypoallergens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |
|
| EEER | Examination request |
Effective date: 20170308 |